References
- Nguyen ND, Ahlborg HG, Centre RJ, et al. Residual lifetime risk of fractures in women and men. J Bone Miner Res 2007;22:781–8
- Kanis JA on behalf of the WHO Scientific Group. Assessment of osteoporosis at the primary health care level. Sheffield, UK: University of Sheffield; 2007
- Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001;12:519–28
- van Staa TP, Geusens P, Kanis JA, et al. A simple clinical score for estimating the long-term risk of fracture in postmenopausal women. QJM 2006;99:673–82
- Ettinger B, Hilier TA, Pressman A, et al. Simple computer model for calculating and reporting 5-year osteoporotic fracture risk in postmenopausal women. J Womens Health (Larchmt) 2005;14:159–71
- Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. Br Med J 2009;339:b4229
- Kanis JA, Johnell O, Oden A, et al. FRAXTM and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385–97
- Siris ES, Baim S, Nattiv A. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. Postgrad Med 2010;122:82–90
- Nguyen ND, Frost SA, Centre JR, et al. Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int 2007;18:1109–17
- Nguyen ND, Frost SA, Centre JR, et al. Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 2008;19:1431–44
- Sandu SK, Nguyen ND, Centre JR, et al. Prognosis of fracture: evaluation of predictive accuracy of the FRAXTM algorithm and Garvan nomogram. Osteoporos Int 2010;21:863–71
- Adler RA, Hastings FW, Petkov VI. Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX. Osteoporos Int 2010;21:647–53
- Saylor PJ, Kaufman DS, Michaelson MD, et al. Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer. J Urol 2010;183:2200–5
- Leslie WD, Lix LM, Johansson H, et al.; Manitoba Bone Density Program. (2010) Independent clinical validation of a Canadian FRAX((R)) tool: fracture prediction and model calibration. J Bone Miner Res 2010;25:2350–8
- DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837–45
- Pluskiewicz W, Adamczyk P, Franek E, et al. Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.-Conformity between methods and their clinical utility. Bone 2010;46:1661–7
- Sambrook PN, Flahive J, Hooven FH, et al. Predicting fractures in and international cohort using risk factor algorithms without BMD. J Bone Miner Res 2011;26:2770–7
- Kanis JA, Oden A, Johansson H, McCloskey E. Pitfalls in the external validation of FRAX. Osteoporos Int 2012;23:423–31